Beyond Cholesterol Lowering: Clinical Caution, Personalization, and Nutritional Integration in Statin Therapy

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Nutritional Science

Background:

• Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for atherosclerosis and cardiovascular disease (CVD).
• Statins are standard for LDL-C reduction and secondary CVD prevention, but their role in primary prevention is debated.
• Long-term statin adherence is often limited by adverse effects.

Purpose of the Study:

• To review the clinical effectiveness of statin therapy.
• To examine the influence of nutritional status on statin efficacy, safety, and outcomes.
• To provide evidence-based recommendations for integrating nutritional assessment into statin management.

Main Methods:

• Narrative review of current evidence.
• Focused analysis on nutritional status and statin therapy.
• Evaluation of clinical outcomes and adverse events.

Main Results:

• Statin effectiveness in primary prevention is mixed; some patients show limited benefit even with adequate LDL-C lowering.
• Over half of statin users discontinue therapy within two years due to adverse effects.
• Malnutrition and sarcopenia may impact statin pharmacokinetics and pharmacodynamics, affecting efficacy and safety.
• Statin use can alter nutrition biomarkers, potentially leading to misclassification of nutritional status.

Conclusions:

• Statin prescription requires an individualized, patient-centered approach, contextualizing guideline recommendations.
• Optimal statin effectiveness is achieved through integration with diet, nutritional status, and lifestyle factors.
• Incorporating nutritional assessment can enhance statin tolerability, clinical outcomes, and cardiovascular risk stratification.